Vedolizumab and Ustekinumab Levels in Pregnant Women With Inflammatory Bowel Disease and Infants Exposed In Utero.

Autor: Prentice R; Department of Gastroenterology, Monash Health, Clayton, Victoria, Australia; Department of Gastroenterology, St Vincent's Hospital Melbourne, Fitzroy, Victoria, Australia; Centre of Inflammatory Disease, Department of Medicine, Monash University, Clayton, Victoria, Australia. Electronic address: ralley.prentice@monash.edu., Flanagan E; Department of Gastroenterology, St Vincent's Hospital Melbourne, Fitzroy, Victoria, Australia; University of Melbourne, Parkville, Victoria, Australia., Wright EK; Department of Gastroenterology, St Vincent's Hospital Melbourne, Fitzroy, Victoria, Australia; University of Melbourne, Parkville, Victoria, Australia., Gibson PR; Department of Gastroenterology, Central Clinical School, Monash University and Alfred Health, Melbourne, Victoria, Australia., Rosella S; Department of Gastroenterology, Central Clinical School, Monash University and Alfred Health, Melbourne, Victoria, Australia., Rosella O; Department of Gastroenterology, Central Clinical School, Monash University and Alfred Health, Melbourne, Victoria, Australia., Begun J; Department of Gastroenterology, Mater Hospital, Brisbane, Queensland, Australia., An YK; Department of Gastroenterology, Mater Hospital, Brisbane, Queensland, Australia., Lawrance IC; School of Medicine and Pharmacology, Faculty of Medicine and Dentistry at the University of Western Australia, Perth, Western Australia, Australia; St John of God Subiaco Hospital, Perth, Western Australia, Australia., Kamm MA; Department of Gastroenterology, St Vincent's Hospital Melbourne, Fitzroy, Victoria, Australia; University of Melbourne, Parkville, Victoria, Australia., Sparrow M; Department of Gastroenterology, Central Clinical School, Monash University and Alfred Health, Melbourne, Victoria, Australia., Goldberg R; Department of Gastroenterology, Monash Health, Clayton, Victoria, Australia; Centre of Inflammatory Disease, Department of Medicine, Monash University, Clayton, Victoria, Australia., Prideaux L; Department of Gastroenterology, Monash Health, Clayton, Victoria, Australia., Vogrin S; University of Melbourne, Parkville, Victoria, Australia., Kiburg KV; University of Melbourne, Parkville, Victoria, Australia., Ross AL; Department of Gastroenterology, St Vincent's Hospital Melbourne, Fitzroy, Victoria, Australia., Burns M; Department of Gastroenterology, Monash Health, Clayton, Victoria, Australia., Bell SJ; Department of Gastroenterology, Monash Health, Clayton, Victoria, Australia; Centre of Inflammatory Disease, Department of Medicine, Monash University, Clayton, Victoria, Australia; University of Melbourne, Parkville, Victoria, Australia.

Publikováno v: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association [Clin Gastroenterol Hepatol] 2025 Jan; Vol. 23 (1), pp. 124-133.e7. Date of Electronic Publication: 2024 Mar 15.

Characterisation of biomarkers of intestinal barrier function in response to a high fat/high carbohydrate meal and corticotropin releasing hormone.

Autor: Mogilevski T; Department of Gastroenterology, Central Clinical School, Monash University and Alfred Health, Melbourne, Australia., Rosella S; Department of Gastroenterology, Central Clinical School, Monash University and Alfred Health, Melbourne, Australia., Nguyen A; Department of Gastroenterology, Central Clinical School, Monash University and Alfred Health, Melbourne, Australia., Fitzpatrick J; Department of Gastroenterology, Central Clinical School, Monash University and Alfred Health, Melbourne, Australia., Parker F; Department of Gastroenterology, Central Clinical School, Monash University and Alfred Health, Melbourne, Australia., Halmos EP; Department of Gastroenterology, Central Clinical School, Monash University and Alfred Health, Melbourne, Australia., Gibson PR; Department of Gastroenterology, Central Clinical School, Monash University and Alfred Health, Melbourne, Australia.

Publikováno v: PloS one [PLoS One] 2024 Feb 26; Vol. 19 (2), pp. e0294918. Date of Electronic Publication: 2024 Feb 26 (Print Publication: 2024).

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Guidance for the Management of Patients with Vascular Disease or Cardiovascular Risk Factors and COVID-19: Position Paper from VAS-European Independent Foundation in Angiology/Vascular Medicine.

Autor: Gerotziafas, Grigoris T., Catalano, Mariella, Colgan, Mary-Paula, Pecsvarady, Zsolt, Wautrecht, Jean Claude, Fazeli, Bahare, Olinic, Dan-Mircea, Farkas, Katalin, Elalamy, Ismail, Falanga, Anna, Fareed, Jawed, Papageorgiou, Chryssa, Arellano, Rosella S., Agathagelou, Petros, Antic, Darco, Auad, Luciana, Banfic, Ljiljana, Bartolomew, John R., Benczur, Bela, Bernardo, Melissa B.

Publikováno v: Thrombosis & Haemostasis; 2020, Vol. 120 Issue 12, p1597-1628, 32p

Biomarkers of Intestinal Permeability Are Influenced by Diet in Patients with Ulcerative Colitis—An Exploratory Study.

Autor: Haskey, Natasha^1,2 (AUTHOR) natasha.haskey@ubc.ca, Eisele, Maximillian¹ (AUTHOR) maximilian.eisele@ucalgary.ca, Bruno, Andreina³ (AUTHOR) andreina.bruno@ift.cnr.it, Reimer, Raylene A.⁴ (AUTHOR) reimer@ucalgary.ca, Yousuf, Munazza¹ (AUTHOR) munazza.yousuf1@ucalgary.ca, Taylor, Lorian M.¹ (AUTHOR) lorian.taylor@lyfemd.com, Panaccione, Remo¹ (AUTHOR) rpanacci@ucalgary.ca, Ghosh, Subrata⁵ (AUTHOR) sughosh@ymail.com, Raman, Maitreyi¹ (AUTHOR) mkothand@ucalgary.ca

Publikováno v: Diagnostics (2075-4418). Dec2024, Vol. 14 Issue 23, p2629. 12p.